Vanesa Gutierrez

Malaga, AN 29010, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Association Between Cutaneous Immune-Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer.

Association Between Cutaneous Immune-Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer.

Journal: Journal of clinical medicine

Published: March 01, 2025

Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA.

Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: April 05, 2024

Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer.

Spatially Preserved Multi-Region Transcriptomic Subtyping and Biomarkers of Chemoimmunotherapy Outcome in Extensive-Stage Small Cell Lung Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 12, 2024

Liquid Biopsy as a Tool for the Characterisation and Early Detection of the Field Cancerization Effect in Patients with Oral Cavity Carcinoma.

Liquid Biopsy as a Tool for the Characterisation and Early Detection of the Field Cancerization Effect in Patients with Oral Cavity Carcinoma.

Journal: Biomedicines

Published: August 26, 2021

Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study.

Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study.

Journal: Translational lung cancer research

Published: June 20, 2021

Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451.

Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 08, 2021

Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study.

Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: December 17, 2020

Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study).

Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 31, 2018

Afatinib in patients with squamous cell carcinoma of the lung: current context and the option of oral treatment

Afatinib in patients with squamous cell carcinoma of the lung: current context and the option of oral treatment

Journal: Medicina clinica

Published: July 19, 2016

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain.

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain.

Journal: BMC cancer

Published: June 20, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026